SUPPLEMENT
Q2 2025 — Income statement trends
Q2 2025PDF · 2 pages144 KB
CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q223 Q323 Q423 Q124 Q224 Q324 Q424 Q125 Q225 Revenues: Clearing and transaction fees 1,118.3 1,085.5 1,184.5 1,208.9 1,249.9 1,297.1 1,232.3 1,337.3 1,388.0 Market data and information services 163.1 167.6 167.2 175.4 175.0 178.2 181.6 194.5 198.1 Other Revenue 78.8 84.7 87.6 103.6 107.6 109.1 111.4 110.5 105.9 Total revenues 1,360.2 1,337.8 1,439.3 1,487.9 1,532.5 1,584.4 1,525.3 1,642.3 1,692.0 Expenses: Compensation and benefits 205.7 205.5 212.9 206.0 204.7 218.8 220.8 206.7 221.6 Technology 53.3 55.6 58.5 59.4 64.1 66.6 65.7 65.7 70.9 Professional fees and outside services 37.8 32.2 36.1 33.1 34.7 31.0 33.9 28.5 37.4 Amortization of purchased intangibles 57.0 57.2 55.6 55.2 55.5 55.7 55.3 55.2 56.1 Depreciation and amortization 32.3 31.1 30.7 30.1 28.7 28.2 28.1 27.3 27.3 Licensing and other fee agreements 78.2 79.5 80.4 87.9 85.9 97.6 84.0 96.6 96.2 Other expense 57.3 56.5 101.9 56.6 58.3 62.3 90.4 54.3 53.2 Operating expenses 521.6 517.6 576.1 528.3 531.9 560.2 578.2 534.3 562.7 Operating Income 838.6 820.2 863.2 959.6 1,000.6 1,024.2 947.1 1,108.0 1,129.3 Operating Margin 62% 61% 60% 64% 65% 65% 62% 67% 67% Non-operating Income and Expense Investment income 1,568.2 1,272.5 1,076.9 1,071.3 1,044.5 1,026.8 936.5 892.7 1,518.4 Interest and other borrowing costs (40.2) (39.6) (39.7) (39.9) (40.1) (40.2) (40.7) (41.7) (44.0) Equity in net gains (losses) of unconsolidated subsidiaries 75.1 76.8 66.8 87.2 86.4 86.1 91.2 88.2 99.0 Other non-operating income (expense) (1,425.3) (1,155.6) (961.2) (964.8) (936.9) (920.0) (837.5) (802.4) (1,372.4) Non-operating income (expense) 177.8 154.1 142.8 153.8 153.9 152.7 149.5 136.8 201.0 Income before income taxes 1,016.4 974.3 1,006.0 1,113.4 1,154.5 1,176.9 1,096.6 1,244.8 1,330.3 Income taxes 238.8 224.1 191.4 258.2 271.3 264.1 222.0 288.6 305.2 Net income 777.6 750.2 814.6 855.2 883.2 912.8 874.6 956.2 1,025.1 Less: net income (loss) attributable to NCI - - - - - - - - - Net Income Attributable to CME Group 777.6 750.2 814.6 855.2 883.2 912.8 874.6 956.2 1,025.1 Net Income Attributable to Common Shareholders of CME Group 767.8 740.8 804.3 844.4 872.1 901.3 863.7 944.2 1,012.2 Effective Tax Rate 23.5% 23.0% 19.0% 23.2% 23.5% 22.4% 20.2% 23.2% 22.9% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 2.14 2.06 2.24 2.35 2.43 2.51 2.40 2.63 2.81 Diluted EPS 2.14 2.06 2.24 2.35 2.42 2.50 2.40 2.62 2.81 Weighted average number of common stock shares: Basic Shares 358,940 359,020 359,197 359,258 359,330 359,400 359,568 359,613 359,658 Diluted Shares 359,429 359,619 359,693 359,833 359,869 359,989 360,050 360,227 360,355 Preferred Shares 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 -- 1 of 2 -- CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF NON-GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q223 Q323 Q423 Q124 Q224 Q324 Q424 Q125 Q225 Revenues: Clearing and transaction fees 1,118.3 1,085.5 1,184.5 1,208.9 1,249.9 1,297.1 1,232.3 1,337.3 1,388.0 Market data and information services 163.1 167.6 167.2 175.4 175.0 178.2 181.6 194.5 198.1 Other Revenue 78.8 84.7 87.6 103.6 106.6 109.2 111.3 110.5 105.9 Total revenues 1,360.2 1,337.8 1,439.3 1,487.9 1,531.5 1,584.5 1,525.2 1,642.3 1,692.0 Expenses: Compensation and benefits 194.4 193.5 204.4 196.1 201.7 207.5 218.9 207.8 212.5 Technology 53.3 55.6 58.5 59.4 64.1 66.6 65.7 65.7 70.9 Professional fees and outside services 37.8 32.2 36.1 33.1 34.7 31.0 33.9 25.2 27.0 Amortization of purchased intangibles - - - - - - - - - Depreciation and amortization 31.8 31.1 29.8 29.3 28.7 28.2 28.0 27.3 26.9 Licensing and other fee agreements 78.2 79.5 80.4 87.9 85.9 97.6 84.0 96.6 96.2 Other expense 56.2 56.5 80.3 56.5 58.6 57.9 89.7 52.0 57.7 Operating expenses 451.7 448.4 489.5 462.3 473.7 488.8 520.2 474.6 491.2 Operating Income 908.5 889.4 949.8 1,025.6 1,057.8 1,095.7 1,005.0 1,167.7 1,200.8 Operating Margin 67% 66% 66% 69% 69% 69% 66% 71% 71% Non-operating Income and Expense Investment income 1,564.0 1,276.6 1,068.5 1,061.7 1,033.0 1,022.3 943.8 892.3 1,510.7 Interest and other borrowing costs (40.2) (39.6) (39.7) (39.9) (40.1) (40.2) (40.7) (41.7) (44.0) Equity in net gains (losses) of unconsolidated subsidiaries 88.6 90.4 85.1 100.7 98.8 99.7 104.8 110.4 112.2 Other non-operating income (expense) (1,429.9) (1,157.1) (958.8) (964.8) (936.9) (920.0) (837.5) (802.4) (1,372.4) Non-operating income (expense) 182.5 170.3 155.1 157.7 154.8 161.8 170.4 158.6 206.5 Income before income taxes 1,091.0 1,059.7 1,104.9 1,183.3 1,212.6 1,257.5 1,175.4 1,326.3 1,407.3 Income taxes 254.6 241.7 240.2 272.2 280.4 280.5 256.5 306.4 327.9 Net income 836.4 818.0 864.7 911.1 932.2 977.0 918.9 1,019.9 1,079.4 Less: net income (loss) attributable to NCI - - - - - - - - - Net Income Attributable to CME Group 836.4 818.0 864.7 911.1 932.2 977.0 918.9 1,019.9 1,079.4 Net Income Attributable to Common Shareholders of CME Group 825.9 807.8 853.8 899.7 920.4 964.7 907.4 1,007.1 1,065.8 Effective Tax Rate 23.3% 22.8% 21.7% 23.0% 23.1% 22.3% 21.8% 23.1% 23.3% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 2.30 2.25 2.38 2.50 2.56 2.68 2.52 2.80 2.96 Diluted EPS 2.30 2.25 2.37 2.50 2.56 2.68 2.52 2.80 2.96 Weighted average number of common stock shares: Basic Shares 358,940 359,020 359,197 359,258 359,330 359,400 359,568 359,613 359,658 Diluted Shares 359,429 359,619 359,693 359,833 359,869 359,989 360,050 360,227 360,355 Preferred Shares 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 -- 2 of 2 --